The effects of atrial electrical remodeling on atrial defibrillation thresholds

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 8, 2001, Pages 1208-1215

  Everett, Thomas H ^a   Li, Hui ^a   Michael Mangrum, J ^a   Mastrangelo, Christina ^a   Haines, David E ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Atrial fibrillation; Atrial implantable defibrillator; Defibrillation; Electrical remodeling; Pacing

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOG; ELECTROGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART CATHETER; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE REMODELING; NONHUMAN; TREATMENT OUTCOME;

EID: 0034890389     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.01208.x     Document Type: Article

References (37)

1. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats
2. Electrical remodeling in atrial fibrillation, time course and mechanisms
3. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
4. Electrophysiological mechanisms of perpetuation of atrial fibrillation
5. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs, electrophysiological remodeling
6. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model
7. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling
8. Regional differences in the recovery course of tachycardia-induced changes of atrial electrophysiological properties
9. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation
10. Atrial dispersion of refractoriness
11. Atrial defibrillation: Can modifications in current implantable cardioverter-defibrillators achieve this?
12. Capture window in human atrial fibrillation: Evidence of an excitable gap
13. Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation
14. Low energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results
15. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold
16. Atrial fibrillation detection and r-wave synchronization by Metrix implantable atrial defibrillator. Implications for long-term efficacy and safety
17. Atrioverter: An implantable device for the treatment of atrial fibrillation
18. Specific considerations with the automatic implantable atrial defibrillator
19. Indications for an atrial defibrillator
20. Is the automatic atrial defibrillator a promising approach?
21. Is there any indication for an intracardiac defibrillator for the treatment of atrial fibrillation?
22. Pathophysiology of atrial fibrillation
23. Effect of parenteral d-sotalol on transvenous atrial defibrillation threshold in a canine model of atrial fibrillation
24. The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation
25. Electrical cardioversion after amiodarone administration
26. Energy levels for defibrillation: What is of real clinical importance?
27. Internal cardioversion of atrial fibrillation in sheep
28. Improved internal defibrillation success with shocks timed to the morphology electrogram
29. Arrhythmias/pacing: Effect of atrial fibrillation on atrial refractoriness in humans
30. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations
31. Low energy conversion of atrial fibrillation in the sheep
32. Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways
33. Effects of postshock atrial pacing on atrial defibrillation outcome in the isolated sheep heart
34. Low energy endocardial cardioversion of atrial arrhythmias in humans
35. Initial clinical experience with an implantable human atrial defibrillator
36. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system